menu
    • menu

    Company profile for Vivace Therapeutics

    NEW Drugs in Dev: 2
    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    LEBSA- Your strategic API source for niche molecules.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    At Vivace Therapeutics, we pursue our work with passion, driven by a conviction to help people fight cancer and live life to the fullest. Based in the San Francisco Bay Area, Vivace Therapeutics is an oncology-focused small molecule drug discovery and development company adopting a capital-efficient approach to bring novel therapies to patients in need. Our experienced management team and world-class scientists work to adv...
    At Vivace Therapeutics, we pursue our work with passion, driven by a conviction to help people fight cancer and live life to the fullest. Based in the San Francisco Bay Area, Vivace Therapeutics is an oncology-focused small molecule drug discovery and development company adopting a capital-efficient approach to bring novel therapies to patients in need. Our experienced management team and world-class scientists work to advance promising drugs and therapeutic technologies that we believe can help conquer cancer.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Vivace TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    2929 Campus Drive Suite 150 San Mateo, California 94403
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://vivacetherapeutics.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Vivace Therapeutics' VT3989, Shows Strong Antitumor Activity
    Vivace Therapeutics' VT3989, Shows Strong Antitumor Activity

    19 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/vt3989-vivace-therapeutics-best-in-class-hippo-pathway-targeting-therapy-demonstrates-promising-antitumor-activity-in-refractory-mesothelioma-302588304.html

    PR NEWSWIRE
    19 Oct 2025
    Share Share
    Vivace Hits High Note In Midstage Mesothelioma Trial
    Vivace Hits High Note In Midstage Mesothelioma Trial

    19 Oct 2025

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/esmo-vivace-tunes-ph-3-after-midstage-mesothelioma-trial-hits-high-note

    FIERCE BIOTECH
    19 Oct 2025
    Share Share
    Vivace Therapeutics To Present New Clinical Data at ESMO Congress
    Vivace Therapeutics To Present New Clinical Data at ESMO Congress

    09 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/new-clinical-data-for-vivace-therapeutics-best-in-class-hippo-pathway-targeting-therapy-to-be-presented-in-oral-presentation-at-the-european-society-for-medical-oncology-esmo-congress-2025-302578680.html

    PR NEWSWIRE
    09 Oct 2025
    Share Share
    Vivace Therapeutics' VT3989 Granted Fast Track Designation by US
    Vivace Therapeutics' VT3989 Granted Fast Track Designation by US

    08 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/vivace-therapeutics-vt3989-granted-fast-track-designation-by-the-us-food-and-drug-administration-for-the-treatment-of-mesothelioma-302577269.html

    PR NEWSWIRE
    08 Oct 2025
    Share Share
    Vivace Therapeutics Gets Orphan Drug Designation for VT3989
    Vivace Therapeutics Gets Orphan Drug Designation for VT3989

    30 Jul 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/vivace-therapeutics-announces-receipt-of-orphan-drug-designation-for-vt3989-for-treatment-of-mesothelioma-302516783.html

    PR NEWSWIRE
    30 Jul 2025
    Share Share
    Researchers Report Clinical Proof-of-Concept Data for Vivace ' VT3989
    Researchers Report Clinical Proof-of-Concept Data for Vivace ' VT3989

    17 Apr 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/researchers-report-clinical-proof-of-concept-data-for-vivace-therapeutics-vt3989-a-first-for-a-cancer-drug-targeting-the-hippo-pathway-in-oral-presentation-at-aacr-2023-301798333.html

    PR NEWSWIRE
    17 Apr 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search